MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)

MMC、VICC

• 批准号: 8534727
• 负责人: Samuel Evans Adunyah
• 金额: $ 111.35万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-26 至 2016-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8534727
• 关键词: Address; Advanced Malignant Neoplasm; Advisory Committees; African American; Age; Award; Biology; Biometry; Breast; Cancer Burden; Cancer Center; Cancer Research Infrastructure; Chemistry; Clinical; Clinical Sciences; Clinical Trials; Collaborations; Colorectal; Commit; Communities; Community Healthcare; Community Outreach; Comprehensive Cancer Center; Consensus; Core Facility; Development; Diagnosis; Discipline; Discipline of Nursing; Doctor of Philosophy; Education; Educational workshop; Effectiveness; Environment; Epidemiology; Faculty; Funding; Goals; Histopathology; Human Resources; Incidence; Institution; Joints; Lead; Leadership; Malignant Neoplasms; Malignant neoplasm of lung; Measurable; Minority; Minority-Serving Institution; Mission; Monitor; Nanotechnology; National Cancer Institute; Outcome; Participant; Phase; Pilot Projects; Population; Positioning Attribute; Prevention strategy; Primary Prevention; Prostate; Recruitment Activity; Relative (related person); Research; Research Infrastructure; Research Personnel; Research Training; Resources; Science; Scientist; Services; Strategic Planning; Targeted Research; Tennessee; Training; Training Programs; Translational Research; Triad Acrylic Resin; Underrepresented Minority; United States; Universities; Work; anticancer research; base; cancer education; cancer health disparity; cancer therapy; cancer type; career development; design; graduate student; health disparity; improved; medical schools; member; mortality; multidisciplinary; outreach; population based; programs; research and development; success; undergraduate student

DESCRIPTION (provided by applicant): Strong ties have developed between cancer researchers at Meharry Medical College (MMC), Tennessee State University (TSU) and Vanderbilt-lngram Cancer Center (VICC) resulting in this formal Cancer Partnership. Our Partnership is dedicated to enhancing the strengths and eliminating the weaknesses of our three institutions as we move toward our shared goal of eliminating cancer disparities in the US. The U54 award is the bedrock of this collaboration and has moved our collaborative research more forcefully toward a relationship that is based on reciprocity and stronger mutual benefit. The overall objectives of this competing renewal application are: (1) to increase and stabilize the competitive cancer research capability of MMC and TSU; (2) to create stable, long-term collaborative relationships between MMC, TSU and the VICC in cancer research, research training, career development and cancer outreach; and (3) to improve the effectiveness of VICC research, training, career development, cancer education and cancer outreach activities specifically designed to benefit minority populations in the region served by VICC. Funds provided by this U54 will solidify our collaboration. During this phase of our Cancer Partnership, we continue to concentrate on amassing sufficient infrastructure for cancer research that will strengthen reciprocity between MMC, TSU and VICC. In addition to funding two full projects and two pilot studies involving collaborators from all three institutions, funds will be used to recruit investigators to TSU and VICC and to strengthen infrastructure in basic, epidemiologic and clinical cancer research through the support of core facilities providing expertise in biostatistics, clinical trial accruals, histopathology and cancer outreach. All activities involve coordinated, well-planned interactions between MMC, TSU and VICC and will be monitored by an Internal Advisory Committee composed of members from each institution and a Program Steering Committee composed of external, nationally-recognized cancer investigators and representation from the National Cancer Institute. A sustained and comprehensive Cancer Partnership is of immense benefit to the three participating institutions as well as the mid-South region of the US. The institution's complementary strengths will help the Cancer Partnership establish effective cancer research and increase training opportunities at two minority-serving institutions enhance community- and population-based science research targeting minority cancer-related disparities and increase training of minority scientists at an NCI-funded Comprehensive Cancer Center.

描述（由申请人提供）：在Meharry医学院（MMC），田纳西州立大学（TSU）（TSU）和Vanderbilt-Lngram癌症中心（VICC）的癌症研究人员之间建立了牢固的联系，从而建立了正式的癌症伙伴关系。当我们朝着消除美国癌症差异的共同目标时，我们的合作伙伴关系致力于增强三个机构的优势并消除三个机构的劣势。 U54奖是这项合作的基石，并将我们的协作研究更加有力地迈向了基于互惠和更强大的互惠率的关系。这种竞争性更新应用的总体目标是：（1）提高和稳定MMC和TSU的竞争性癌症研究能力； （2）在癌症研究，研究培训，职业发展和癌症外展中建立MMC，TSU与VICC之间的稳定，长期的合作关系； （3）提高VICC研究，培训，职业发展，癌症教育和癌症外展活动的有效性，旨在使VICC服务的少数群体受益。该U54提供的资金将巩固我们的合作。在我们的癌症伙伴关系的这一阶段，我们继续专注于积累足够的基础设施来进行癌症研究，以增强MMC，TSU和VICC之间的互惠。除了资助所有三个机构的合作者的两个完整项目和两项试点研究外，资金还将用于招募调查员到TSU和VICC，并通过支持Biostatistics Biostatistics Biostatistics的核心设施来加强基础，流行病学和临床癌症研究中的基础设施，临床试验，临床试验探测，临床试验探讨，病态和癌症，癌症，癌症。所有活动均涉及MMC，TSU和VICC之间的协调，精心计划的相互作用，并将由由每个机构的成员组成的内部咨询委员会以及由国家癌症研究所的外部，全国认可的癌症研究者和代表性组成的计划指导委员会的监视。持续而全面的癌症伙伴关系对三个参与机构以及美国中南部地区带来了巨大的好处。该机构的补充优势将有助于癌症伙伴关系建立有效的癌症研究，并增加两个少数族裔服务机构的培训机会，以增强针对少数癌症相关差异的社区和基于人群的科学研究，并增加NCI资助的综合癌症中心的少数群体科学家的培训。